Alibaba Health Information Technology Limited (HKG:0241)

Market Cap	97.13B
Revenue (ttm)	31.39B
Net Income (ttm)	1.34B
Shares Out	16.08B
EPS (ttm)	0.09
PE Ratio	69.41
Forward PE	45.49
Dividend	n/a
Ex-Dividend Date	n/a

Volume	748,634,864
Average Volume	324,620,176
Open	6.10
Previous Close	5.76
Day's Range	5.80 - 6.29
52-Week Range	2.59 - 6.70
Beta	1.15
RSI	80.26
Earnings Date	Feb 12, 2025

About HKG:0241

Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. The company offers a range of prescription and over-the-counter drugs, nutritional supplements, medical devices, contact lenses, health food, adult and family planning products, healthcare and skincare products, and various other health-related products. It also provides medical and healthcare services, includi...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 1998
• Employees: 1,435
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 0241

Financial Performance

In 2023, HKG:0241's revenue was 27.03 billion, an increase of 0.98% compared to the previous year's 26.76 billion. Earnings were 883.48 million, an increase of 64.93%.

Financial numbers in CNY